Status of 25-hydroxyvitamin D deficiency and effect of vitamin D receptor gene polymorphisms on bone mineral density in thalassemia patients of North India

References

• Domrongkitchaiporn S, Sirikulchayanonta V, Angchaisuksiri P, Stitchantrakul W, Kanokkantapong C, Rajatanavin R. Abnormalities in bone mineral density and bone histology in thalassemia. J Bone Miner Res. 2003;18:1682–8.
   PubMed Web of Science ®Google Scholar
• Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br J Haematol. 2004;127:127–39.
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med. 2004;116:634–9.
   PubMed Web of Science ®Google Scholar
• Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res. 2004;19:1221–30.
   PubMed Web of Science ®Google Scholar
• Kanan RM, Varanasi SS, Francis RM, Parker L, Datta HK. Vitamin D receptor gene start codon polymorphism (FokI) and bone mineral density in healthy male subjects. Clin Endocrinol. 2000;53:93–8.
   PubMed Web of Science ®Google Scholar
• Tajima O, Ashizawa N, Ishii T, Amagai H, Mashimo T, Liu LJ, et al. Interaction of the effects between vitamin D receptor polymorphism and exercise training on bone metabolism. J Appl Physiol. 2000;88:1271–6.
   PubMed Web of Science ®Google Scholar
• Bell NH, Morrison NA, Nguyen TV, Eisman J, Hollis BW. ApaI polymorphisms of the vitamin D receptor predict bone density of the lumbar spine and not racial difference in bone density in young men. J Lab Clin Med. 2001;137:133–40.
   PubMed Web of Science ®Google Scholar
• Braga V, Sangalli A, Malerba G, Mottes M, Mirandola S, Gatti D, et al. Relationship among VDR (BsmI and FokI), COLIA1, and CTR polymorphisms with bone mass, bone turnover markers, and sex hormones in men. Calcif Tissue Int. 2002;70:457–62.
   PubMed Web of Science ®Google Scholar
• Morrison NA, George PM, Vaughan T, Tilyard MW, Frampton CM, Gilchrist NL. Vitamin D receptor genotypes influence the success of calcitriol therapy for recurrent vertebral fracture in osteoporosis. Ann Intern Med. 2006;145:302–4.
   PubMedGoogle Scholar
• Poncz M, Solowiejczyk D, Harpel B, Mory Y, Schwartz E, Surrey S. Construction of human gene libraries from small amounts of peripheral blood: analysis of beta-like globin genes. Hemoglobin. 1982;6:27–36.
   PubMed Web of Science ®Google Scholar
• Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, et al. Prediction of bone density from vitamin D receptor alleles. Nature. 1994;367:284–7.
   PubMed Web of Science ®Google Scholar
• Lundin AC, Söderkvist P, Eriksson B, Bergman-Jungeström M, Wingren S. Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res. 1999;59:2332–4.
   PubMed Web of Science ®Google Scholar
• Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B, Feldman D. The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res. 1997;12:1043–8.
   PubMed Web of Science ®Google Scholar
• Vichinsky EP. The morbidity of bone disease in thalassemia. Ann N Y Acad Sci. 1998;850:344–8.
   PubMed Web of Science ®Google Scholar
• Vogiatzi MG, Autio KA, Schneider R, Giardina PJ. Low bone mass in prepubertal children with thalassemia major: insights into the pathogenesis of low bone mass in thalassemia. J Pediatr Endocrinol Metab. 2004;17:1415–21.
   PubMed Web of Science ®Google Scholar
• Dresner Pollak R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia. Br J Haematol. 2000;111:902–7.
   PubMed Web of Science ®Google Scholar
• Ferrara M, Matarese SM, Francese M, Borrelli B, Coppola A, Coppola L, et al. Effect of VDR polymorphisms on growth and bone mineral density in homozygous beta thalassaemia. Br J Haematol. 2002;117:436–40.
   PubMed Web of Science ®Google Scholar
• El-Edel RH, Ghonaim MM, Abo-Salem OM, El-Nemr FM. Bone mineral density and vitamin d receptor polymorphism in β-thalassemia major. Pak J Pharm Sci. 2010;23:89–96.
   PubMed Web of Science ®Google Scholar
• Hamed HM, Galal A, El Ghamrawy M, AbdEl Azeem K, A El Ghoroury E, Rasheed MA, et al. Vitamin D receptor polymorphisms and indices of bone turnover and bone mass in Egyptian children with sickle cell disease. Res J Med Med Sci. 2010;5:1–7.
   Google Scholar
• Nakamura K, Ueno K, Nishiwaki T, Okuda Y, Saito T, Tsuchiya Y, et al. Nutrition, mild hyperparathyroidism, and bone mineral density in young Japanese women. Am J Clin Nutr. 2005;82:1127–33.
   PubMed Web of Science ®Google Scholar
• Vupputuri MR, Goswami R, Gupta N, Ray D, Tandon N, Kumar N. Prevalence and functional significance of 25-hydroxyvitamin D deficiency and vitamin D receptor gene polymorphisms in Asian Indians. Am J Clin Nutr. 2006;83:1411–9.
   PubMed Web of Science ®Google Scholar
• Pirinççioğlu AG, Akpolat V, Köksal O, Haspolat K, Söker M. Bone mineral density in children with beta-thalassemia major in Diyarbakir. Bone. 2011;49(4):819–23.
   PubMed Web of Science ®Google Scholar
• Frisk P, Arvidson J, Ljunggren O, Gustafsson J. Decreased bone mineral density in young adults treated with SCT in childhood: the role of 25-hydroxyvitamin D. Bone Marrow Transpl. 2011;47(5):657–62.
   PubMed Web of Science ®Google Scholar
• De Sanctis V, Borsari G, Brachi S, Gubellini E, Gamberini MR, Carandina G. A rare cause of heart failure in iron-overload thalassaemic patients-primary hypoparathyroidism. Georgian Med News. 2008;156:111–3.
   PubMedGoogle Scholar
• Chatterton BE, Thomas CM, Schultz CG. Liver density measured by DEXA correlates with serum ferritin in patients with beta-thalassemia major. J Clin Densitom. 2003;6:283–8.
   PubMed Web of Science ®Google Scholar
• Wu W, Zhi XM, Li DF, Lin K, Xu L, Yang YH. Vitamin D receptor gene polymorphism is not associated with bone mineral density of pre-menopausal women in Guangzhou. Nan Fang Yi Ke Da Xue Xue Bao. 2007;27:364–6.
   PubMedGoogle Scholar
• Spector TD, Keen RW, Arden NK, Morrison NA, Major PJ, Nguyen TV, et al. Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. BMJ. 1995;310:1357–60.
   PubMed Web of Science ®Google Scholar
• Nguyen TV, Esteban LM, White CP, Grant SF, Center JR, Gardiner EM, et al. Contribution of the collagen I alpha 1 and vitamin D receptor genes to the risk of hip fracture in elderly women. J Clin Endocrinol Metab. 2005;90:6575–9.
   PubMed Web of Science ®Google Scholar
• Gogas Yavuz D, Keskin L, Kıyıcı S, Sert M, Yazıcı D, Sahin I, et al. Vitamin D receptor gene BsmI, FokI, ApaI, TaqI polymorphisms and bone mineral density in a group of Turkish type 1 diabetic patients. Acta Diabetol. 2011;48(4):329–36.
   PubMed Web of Science ®Google Scholar